Bespoke circulating tumor DNA as a biomarker for treatment response in a refractory Merkel cell carcinoma patient

por John Yeakel, MD, Aarthi Kannan, BA, Nicole Hook Rattigan, PhD, Maki Yamamoto, MD, Alexey Aleshin, MD, MBA, Jeremy P. Harris, MPhil, MD, Ling Gao, MD, PhD
Publicado 2021